TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | 2 | 11 | 12 | 64 | 30 | 24 |
| S | %wins | 100 | 0 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/20/07 16:39 | 6/19/07 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Landy Hal | MA | O | VP | M.d | 110 | 2.75 | 0 | 40 | 10 | D | 89 | 38 | 42 | 25 | 10 | 0 | 11 | -1 | 0 | 2 | 11 | 12 | 64 | 30 | |
6/20/07 16:39 | 6/19/07 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Landy Hal | MA | O | VP | S.d | -115 | 3.82 | 0 | -30 | -75 | 10 | D | 89 | 38 | 42 | 25 | 10 | 0 | 11 | -1 | 0 | 2 | 11 | 12 | 64 | 30 |
6/30/04 17:24 | 6/29/04 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Landy Hal | MA | O | VP | M.d | 0 | 0.0100 | 1 | 15 | New | 15 | D | 14 | -52 | -41 | -21 | -9 | -16 | -6 | 3 | -2 | -4 | -37 | -23 | -3 | -14 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |